Cambridge Investment Research Advisors, Inc.
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 1419186
FAIRFIELD, IA
Position in PBH
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$2,700,044
-$136,955 QoQ
Shares Held
45,555
-0.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $25,629,271 across 19 Drug Manufacturers - Specialty & Generic names. PBH ranks #6 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
69,851 | $5,298,198 | |
| 2 | ZTS |
Zoetis Inc.
|
30,836 | $3,645,123 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,575 | $3,305,863 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
95,052 | $2,862,966 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
122,762 | $2,774,421 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
45,555 | $2,700,044 | |
| 7 | VTRS |
Viatris Inc
|
113,737 | $1,536,586 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
61,872 | $1,284,462 |
All Filings in PBH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,700,044 | 45,555 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,836,999 | 45,988 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,108,308 | 33,787 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,482,296 | 31,087 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||